Back to results
US 8,337,857 B2Granted
Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
AssigneesInstitut Pasteur, Centre National De La Recherche Scientifique
InventorsFrederic Tangy, Marianne Lucas-Hourani, Erika Navarro-Sanchez, Marie-Pascale Frenkiel, Hugues Bedouelle, Chantal Combredet, Philippe Despres
Life of this patent
Estimating the term…
Abstract
The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
Claims21
A chimeric polypeptide comprising a subdomain of the E protein of Flaviviridae bound to a subdomain of the membrane M protein of Flaviviridae;
- wherein said chimeric polypeptide comprises an amino acid sequence selected from the group consisting of:
- amino acids 19 to 162 of SEQ ID NO:
- 3;
- amino acids 21 to 168 of SEQ ID NO:
- 6;
- amino acids 21 to 132 of SEQ ID NO:
- 12;
- amino acids 18 to 624 of SEQ ID NO:
- 20;
- amino acids 18 to 609 of SEQ ID NO:
- 21;
- amino acids 18 to 624 of SEQ ID NO:
- 22;
- amino acids 18 to 489 of SEQ ID NO:
- 23;
- and
- amino acids 21 to 474 of SEQ ID NO:
- 24.
15 more elements
Dependencies are inferred from the claim text.